Interleukin 12 (IL12) Antibody (Biotin)

Este producto es parte de IL12A - interleukin 12A
Product Graph
637€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interleukin 12 (IL12) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx411702
tested applications
ELISA, WB

Description

Interleukin 12 (IL12) Antibody (Biotin) is a Goat Polyclonal antibody against Interleukin 12 (IL12).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Interleukin 12 (IL12)
Host
Goat
Reactivity
Mouse
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Biotin
Isotype
IgG
Purification
Purified
Size 1
50 µg
Form
Lyophilized
Tested Applications
ELISA, WB
Buffer
PBS.
Availability
Shipped within 3-7 working days.
Storage
Store lyophilized at 2°C to 8°C. After reconstitution, aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P43431, P43432
Alias
P35,CLMF,NFSK,NKSF1,IL-12A,Cytotoxic lymphocyte maturation factor 35 kDa subunit,CLMF p35,IL-12 subunit p35,NK cell stimulatory factor chain 1
Background
Antibody anti-IL12A
Status
RUO

Descripción

Interleukin 12A (IL12A) is a subunit of the heterodimeric cytokine interleukin-12, which plays a pivotal role in the immune system by bridging innate and adaptive immunity. IL12A, also known as IL-12p35, pairs with the IL12B subunit (IL-12p40) to form the active cytokine IL-12, which is essential for inducing T-helper 1 (Th1) immune responses. IL12A is produced by activated antigen-presenting cells, such as macrophages and dendritic cells, in response to infections or immune challenges. It functions by stimulating natural killer (NK) cells and CD4+ T-cells to produce interferon-gamma (IFN-γ), a cytokine critical for pathogen clearance and enhancing cytotoxic activities. Dysregulation of IL12A expression has been associated with autoimmune diseases, chronic inflammation, and cancer. Therapeutic strategies targeting IL12A, including IL-12 inhibitors or engineered cytokines, are being explored for managing these conditions and for enhancing anti-tumor immune responses.

Related Products

AQ-H0176-B

Human HS-IL-12 p70 (High sensitive Interleukin 12 p70) high sensitive Accquant ELISA Kit

Ver Producto
EB0170

Bovine IL-12A (Interleukin-12 subunit alpha) ELISA Kit

Ver Producto
ECA0034

Canine IL-12/P70 (Interleukin 12 (P70)) ELISA Kit

Ver Producto